• Health Care M&A Deals, September 18, 2020

    The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our Deal Search Online database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. The largest deal... Read More »
  • MetLife Acquires Versant Health

    MetLife, Inc. (NYSE: MET) has entered the healthcare M&A market. Last week, the company announced the acquisition of Versant Health, the parent company of Davis Vision and Superior Vision, two major vision care and insurance brands with a combined 35 million members. Centerbridge Partners and an investor group including FFL Partners are... Read More »
  • CloudMD Expands Patient Engagement Portfolio

    CloudMD Software & Services Inc. (OTCMKTS: DOCRF) just keeps rolling out new deals and acquisitions. The company has been very active this year, with six acquisitions on the books so far across various sectors, according to search results in our Deal Search Online database. Last week, CloudMD acquired Toronto-based iMD Health Global Corp. for... Read More »
  • Trulieve Cannabis Boosts Its Market Reach

    Trulieve Cannabis Corp. (OTC: TCNNF), a vertically integrated “seed-to-sale” company and the first licensed medical cannabis company in the state of Florida, announced two new transactions last week. M&A activity in the medical marijuana market has been quiet throughout 2020 and 2019, after experiencing somewhat of a boom in 2018,... Read More »
  • A Busy Week for Home Health & Hospice Deals

    It was a busy week for home health & hospice (HH&H) transactions. Results from our Deal Search Online database show there were four announced last week alone, half of September’s total so far. Half of the deals were completed by private equity-backed companies, which highlights the continued interest in HH&H from PE firms. Jet... Read More »
Health Care M&A Deals, September 18, 2020

Health Care M&A Deals, September 18, 2020

The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our Deal Search Online database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. The largest deal of the week is MetLife, Inc.’s acquisition of Versant Health for roughly $1.68 billion. With this acquisition, MetLife will become the third largest U.S. vision insurer by membership. The transaction will strengthen and differentiate MetLife’s vision benefit offering with one of the industry’s broadest networks of providers and plan options.... Read More »
Health Care M&A Deals, September 18, 2020

Health Care M&A Deals, September 11, 2020

The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our Deal Search Online database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. The largest deal of the week is the divestment of MEDNAX Radiology Solutions by MEDNAX, Inc. (NYSE: MD) for $885 million. MEDNAX Radiology Solutions, which consists of more than 300 onsite radiologists who primarily serve patients in Connecticut, Florida, Nevada, Tennessee and Texas, and more than 500 teleradiologists, who serve patients in all 50 states. Its physicians interpret 11.8... Read More »
How Has COVID-19 Shaped the Healthcare M&A Market?

How Has COVID-19 Shaped the Healthcare M&A Market?

Examining the healthcare M&A market in 2019 may seem like a strange endeavor since, for many of us, it feels like an entirely different era. But there’s value in analyzing how the healthcare M&A market in August 2020 differed from the one in August 2019, even if they both represent radically different times. The snapshot of the past will help us see how the market has changed, identifying new trends and creating a roadmap for future acquisitions.  In August 2019, there were 149 transactions publicly announced, with $28.03 billion in disclosed spending, according to Deal Search Online. Transactions in the services sectors comprised the majority of activity in August 2019 at... Read More »
Health Care M&A Deals, September 18, 2020

Health Care M&A Deals, September 4, 2020

The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our Deal Search Online database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. The largest deal of the week is Nestle Health Science’s acquisition of Aimmune Therapeutics, Inc. for $2.6 billion. Nestle Health Science is acquiring Aimmune Therapeutics through its wholly-owned subsidiary, Societe des Produits Nestle S.A. The acquisition is an extension of Nestle Health Science’s food allergy portfolio, creating a broader spectrum of... Read More »
Health Care M&A Deals, September 18, 2020

Health Care M&A Deals, August 28, 2020

The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our Deal Search Online database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. The largest deal of the week is Royal Philips’ acquisition of Intact Vascular, Inc. for $360 million. Intact Vascular will enhance Philips’ image-guided therapy portfolio, combining Philips’ interventional imaging platform and diagnostic and therapeutic devices with Intact Vascular’s unique, specialized implantable device to optimize the treatment of patients with Peripheral... Read More »
Health Care M&A Deals, September 18, 2020

Health Care M&A Deals, August 21, 2020

The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our Deal Search Online database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. The largest deal of the week is Johnson & Johnson’s $6.5 billion acquisition of Momenta Pharmaceuticals, Inc., which provides an opportunity for JNJ to broaden its portfolio in immune-mediated diseases and autoantibody-driven diseases. To subscribe to our Health Care M&A deals chart and more, visit our membership... Read More »